<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35355229</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Clinical and electrophysiological characteristics of respiratory onset amyotrophic lateral sclerosis: a single-centre study.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>397</EndPage><MedlinePgn>391-397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-022-01936-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We compared the clinical characteristics of patients with respiratory, bulbar and limb onset amyotrophic lateral sclerosis (ALS) who visited a single tertiary centre for 8&#xa0;years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Total of 115 ALS patients with respiratory, bulbar and limb onset ALS, including sex, body mass index (BMI), presence of lung disease, age at diagnosis, disease duration after initial symptoms, ALS Functional Rating Scale (ALSFRS-R) and progression rate (Delta-FS), pulmonary function, amplitude and distal latency (DL) of the phrenic nerves and blood creatine kinase (CK) and uric acid levels were collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of respiratory, bulbar and limb onset ALS were 5.2%, 28.7% and 66.1%, respectively. The mean age at diagnosis and ALSFRS-R were 67.8&#x2009;&#xb1;&#x2009;5.5, 63.8&#x2009;&#xb1;&#x2009;10.1 and 59.2&#x2009;&#xb1;&#x2009;11.7 in the descending order. The mean amplitude (0.18&#x2009;&#xb1;&#x2009;0.10&#xa0;mV) and DL (9.5&#x2009;&#xb1;&#x2009;1.7&#xa0;ms) of the phrenic nerves were significantly decreased and prolonged in respiratory onset ALS compared with other types of ALS patients. Patients with respiratory onset ALS had normal creatine kinase (CK) levels, whereas patients with other types of ALS had increased CK levels.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although rare, respiratory onset ALS may occur and should be considered during the initial differential diagnosis. In this study, patients with respiratory onset ALS were characterised by male predominance, with a higher baseline ALSFRS-R, lower BMI and phrenic nerve study well discriminated respiratory onset ALS from bulbar or limb onset ALS patients.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to Belgian Neurological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Min Cheol</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Sang Gyu</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Medical Statistics, College of Medicine, Catholic University of Daegu, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jin-Mo</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dongguk University College of Medicine, Dongguk University Gyeongju Hospital, Gyeongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Donghwi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jin-Sung</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-5506-9206</Identifier><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Hoguk-ro 807, Buk-gu, Daegu, Republic of Korea. neurojspark@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Phrenic nerve</Keyword><Keyword MajorTopicYN="N">Pulmonary function test</Keyword><Keyword MajorTopicYN="N">Respiratory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35355229</ArticleId><ArticleId IdType="doi">10.1007/s13760-022-01936-x</ArticleId><ArticleId IdType="pii">10.1007/s13760-022-01936-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gordon PH (2013) Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 4:295&#x2013;310</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2013.0400295</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId><ArticleId IdType="pmc">3794725</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ et al (2010) Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler 11:369&#x2013;373</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903420140</ArticleId><ArticleId IdType="pubmed">20001488</ArticleId><ArticleId IdType="pmc">3182546</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Mitsumoto H, Hays AP (2003) Amyotrophic lateral sclerosis. Sci Aging Knowledge Environ 3;2003:dn2</Citation></Reference><Reference><Citation>Shoesmith CL, Findlater K, Rowe A, Strong MJ (2007) Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 78:629&#x2013;631</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.103564</ArticleId><ArticleId IdType="pubmed">17088331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Grand&#x2019;Maison F, Brown JD, Bolton CF (1997) Motor neuron disease presenting as acute respiratory failure: electrophysiological studies. Muscle Nerve 20:517&#x2013;519</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199704)20:4&lt;517::AID-MUS20&gt;3.0.CO;2-U</ArticleId><ArticleId IdType="pubmed">9121515</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) World federation of neurology research group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Matias T, Coelho F, Evangelista T, Pinto A, Luis ML (1996) Motor neuron disease presenting with respiratory failure. J Neurol Sci 139:117&#x2013;122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00089-5</ArticleId><ArticleId IdType="pubmed">8899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265&#x2013;267</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton CF (2008) Phrenic nerve conduction studies: technical aspects and normative data. Muscle Nerve 38:1658&#x2013;1659</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21128</ArticleId><ArticleId IdType="pubmed">19016537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton CF (1993) AAEM minimonograph #40: clinical neurophysiology of the respiratory system. Muscle Nerve 16:809&#x2013;818</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880160802</ArticleId><ArticleId IdType="pubmed">8332132</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Park D (2017) The terminal latency of the phrenic nerve correlates with respiratory symptoms in amyotrophic lateral sclerosis. Clin Neurophysiol 128:1625&#x2013;1628</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2017.06.039</ArticleId><ArticleId IdType="pubmed">28719826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (2010) ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 11:379&#x2013;382</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903426543</ArticleId><ArticleId IdType="pubmed">20001486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Aloizou AM, Florou D et al (2018) Body mass index and survival from amyotrophic lateral sclerosis: a meta-analysis. Neurol Clin Pract 8:437&#x2013;444</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000521</ArticleId><ArticleId IdType="pubmed">30564498</ArticleId><ArticleId IdType="pmc">6276330</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmins HC, Saw W, Cheah BC, Lin CS, Vucic S, Ahmed RM et al (2017) Cardiometabolic health and risk of amyotrophic lateral sclerosis. Muscle Nerve 56:721&#x2013;725</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25547</ArticleId><ArticleId IdType="pubmed">28029705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Caga J, Devenney E, Hsieh S, Bartley L, Highton-Williamson E et al (2016) Cognition and eating behaviour in amyotrophic lateral sclerosis: effect on survival. J Neurol 263:1593&#x2013;1603</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8168-2</ArticleId><ArticleId IdType="pubmed">27260291</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A et al (2018) Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry 89:1016&#x2013;1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyrignac C, Poirier J, Degos JD (1985) Amyotrophic lateral sclerosis presenting with respiratory insufficiency as the primary complaint. Clinicopathological study of a case. Eur Neurol 24:115&#x2013;120</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000115771</ArticleId><ArticleId IdType="pubmed">3979416</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen AA, Appel SH (2006) Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 77:390&#x2013;392</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.072660</ArticleId><ArticleId IdType="pubmed">16484652</ArticleId><ArticleId IdType="pmc">2077717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>